DDInter1250 DDInter1147
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from *Neisseria meningitidis* serogroup C. *N. meningitidis* is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
Muromonab {u} may cause a minor interaction that can limit clinical effects when taken with {v} Zinc gluconate
Muromonab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ocrelizumab
Muromonab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Anakinra
Muromonab {u} may lead to a major life threatening interaction when taken with {v} Natalizumab
Muromonab {u} may lead to a major life threatening interaction when taken with {v} Etanercept
Muromonab may cause a minor interaction that can limit clinical effects when taken with Zinc gluconate
Muromonab may cause a moderate interaction that could exacerbate diseases when taken with Ocrelizumab
Muromonab may cause a moderate interaction that could exacerbate diseases when taken with Anakinra
Muromonab may lead to a major life threatening interaction when taken with Natalizumab
Muromonab may lead to a major life threatening interaction when taken with Etanercept